Showing results (241-250 of 325) with videos related to
Sort By:
Pageof 33
Seminars in Thrombosis and Hemostasis|November 5, 1999
Acquired defects of fibrinolysis associated with thrombosisJ Fareed, D A Hoppensteadt, W P Jeske, et al.Thrombosis Research|April 1, 1994
Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparinR Kijowski, D Hoppensteadt, J Walenga, et al.Thrombosis Research|June 1, 1997
Topical application of low molecular weight heparin in a rabbit traumatic anastomosis modelK Fu, R Izquierdo, D Vandevender, et al.Seminars in Thrombosis and Hemostasis|January 1, 1995
Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparinsW Jeske, J C Lormeau, D Callas, et al.Current Pharmaceutical Design|April 14, 2004
Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature reviewH L Messmore, E Coyne, W H Wehrmacher, et al.Seminars in Thrombosis and Hemostasis|January 1, 1991
Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparinsH L Messmore, B Griffin, M Koza, et al.Thrombosis Research|December 12, 2001
Singlet oxygen (1O(2)) disrupts platelet aggregatesT W Stief, U Feek, A Ramaswamy, et al.Journal of Pharmaceutical Sciences|June 1, 1995
Molecular profiling and weight determination of heparins and depolymerized heparinsA Ahsan, W Jeske, D Hoppensteadt, et al.Thrombosis Research|June 1, 1989
Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparinC Doutremepuich, E Deharo, M Guyot, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 26, 2003
In vitro simulation of therapeutic plasmatic fibrinolysisT W Stief, R Bünder, A Richter, et al.Pageof 33